`

AnHorn Medicines

Biotechnology Research

Specialities :
Drug discovery
New class medicine
Drug research
Targeted protein degradation
And protac
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About AnHorn Medicines

What does Anhorn medicines do?+

AnHorn Medicines is a novel drug discovery company with a strong pipeline, offering therapies that target and degrade disease-related proteins. Our mission is to develop new class of drugs BIGPRO (Bi-functional liGand induced PROteolysis) under the foundation of Targeted Protein Degradation (TPD), to address a broad range of life-threatening and life-impairing diseases. We focus on novel therapies for cancer, neurodegeneration, and aging diseases. We are turning innovation into new therapeutics new opportunities to target difficult-to-treat diseases and diseases plagued by drug resistance

What are Anhorn medicines's specialties? +

Drug discovery,new class medicine,drug research,targeted protein degradation,and protac

What is Anhorn medicines's industry? +

Anhorn medicines operates in the Biotechnology research industry.

What is Anhorn medicines's revenue? +

Anhorn medicines's revenue is 11m - 100m

What is Anhorn medicines's company size? +

Anhorn medicines has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.